Konstantin Poukalov - 15 Feb 2024 Form 4 Insider Report for LianBio (LIANY)

Reporting relationship
Director
Issuer ticker
LIANY
Reported as of
15 Feb 2024
Net transaction value
-$1.68
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Feb 2024, 17:27:03 UTC
Prior SEC filing
05 Jul 2023
Next SEC filing
14 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alexander Rakitin, for Konstantin Poukalov

Key filing fact

Konstantin Poukalov filed Form 4 for LianBio (LIANY) on 20 Feb 2024.

Key facts

  • This page summarizes Konstantin Poukalov's Form 4 filing for LianBio (LIANY).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Feb 2024, 17:27.

Change

  • Previous filing in this sequence was filed on 05 Jul 2023.
  • Current net transaction value: -$1.68.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIAN transaction

Ordinary Shares

Options Exercise

Transaction value
$91,476
Shares
+36,300
Change %
Price
$2.52
Shares after
36,300
Date
15 Feb 2024
Ownership
Direct
LIAN transaction

Ordinary Shares

Tax liability

Transaction value
$91,478
Shares
-19,218
Change %
-53%
Price
$4.76
Shares after
17,082
Date
15 Feb 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LIAN transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-36,300
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Feb 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
36,300
Exercise price
$2.52
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

Exhibit 24 - Confirming Statement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .